Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Schim

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Headache|July 13, 2020
Moving the Needle, the Clinical PerspectiveJack Schim
Current Medical Research and Opinion|January 27, 2004
Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patientsJack Schim
Current Pain and Headache Reports|September 30, 2010
Pure tension-type headache versus tension-type headache in the migraineurAndrew Blumenfeld, Jack Schim, Jessica Brower
Pain Reports|October 20, 2021
Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label studyBrian Grosberg, Liron Rabany, Tamar Lin, et al.
The Journal of Headache and Pain|July 26, 2019
Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trialsLi Shen Loo, Jessica Ailani, Jack Schim, et al.
Headache|November 6, 2024
Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trialAnna Gryglas-Dworak, Jack Schim, Anders Ettrup, et al.
The Journal of Headache and Pain|September 6, 2022
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 studyRobert P Cowan, Michael J Marmura, Hans-Christoph Diener, et al.
Neurology and Therapy|April 15, 2021
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache CentersElizabeth Faust, Irina Pivneva, Karen Yang, et al.
Headache|February 15, 2013
Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative reviewAndrew Blumenfeld, Avi Ashkenazi, Uri Napchan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Headache|July 13, 2020
Moving the Needle, the Clinical PerspectiveJack Schim
Current Medical Research and Opinion|January 27, 2004
Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patientsJack Schim
Current Pain and Headache Reports|September 30, 2010
Pure tension-type headache versus tension-type headache in the migraineurAndrew Blumenfeld, Jack Schim, Jessica Brower
Pain Reports|October 20, 2021
Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label studyBrian Grosberg, Liron Rabany, Tamar Lin, et al.
The Journal of Headache and Pain|July 26, 2019
Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trialsLi Shen Loo, Jessica Ailani, Jack Schim, et al.
Headache|November 6, 2024
Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trialAnna Gryglas-Dworak, Jack Schim, Anders Ettrup, et al.
The Journal of Headache and Pain|September 6, 2022
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 studyRobert P Cowan, Michael J Marmura, Hans-Christoph Diener, et al.
Neurology and Therapy|April 15, 2021
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache CentersElizabeth Faust, Irina Pivneva, Karen Yang, et al.
Headache|February 15, 2013
Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative reviewAndrew Blumenfeld, Avi Ashkenazi, Uri Napchan, et al.
Pageof 1